These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22083636)
21. AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. Wang Y; Jia L; Hu Z; Entman ML; Mitch WE; Wang Y Kidney Int; 2018 Jan; 93(1):81-94. PubMed ID: 28739141 [TBL] [Abstract][Full Text] [Related]
22. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. Sun YB; Qu X; Caruana G; Li J Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400 [TBL] [Abstract][Full Text] [Related]
23. Temporal control of PDGFRα regulates the fibroblast-to-myofibroblast transition in wound healing. Yao L; Rathnakar BH; Kwon HR; Sakashita H; Kim JH; Rackley A; Tomasek JJ; Berry WL; Olson LE Cell Rep; 2022 Aug; 40(7):111192. PubMed ID: 35977484 [TBL] [Abstract][Full Text] [Related]
24. Connective Tissue Growth Factor Domain 4 Amplifies Fibrotic Kidney Disease through Activation of LDL Receptor-Related Protein 6. Johnson BG; Ren S; Karaca G; Gomez IG; Fligny C; Smith B; Ergun A; Locke G; Gao B; Hayes S; MacDonnell S; Duffield JS J Am Soc Nephrol; 2017 Jun; 28(6):1769-1782. PubMed ID: 28130402 [TBL] [Abstract][Full Text] [Related]
25. [The effect of transforming growth factor β(1) in the transition of bone marrow-derived macrophages into myofibroblasts during renal fibrosis]. Yang Y; Feng XJ; Liu XY; Wang LH; Zheng GP Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):610-613. PubMed ID: 28789496 [TBL] [Abstract][Full Text] [Related]
26. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis. Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371 [TBL] [Abstract][Full Text] [Related]
27. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs. Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500 [TBL] [Abstract][Full Text] [Related]
28. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881 [TBL] [Abstract][Full Text] [Related]
29. The role played by perivascular cells in kidney interstitial injury. Rojas A; Chang FC; Lin SL; Duffield JS Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886 [TBL] [Abstract][Full Text] [Related]
30. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts. Barnes JL; Glass Ii WF Contrib Nephrol; 2011; 169():73-93. PubMed ID: 21252512 [TBL] [Abstract][Full Text] [Related]
31. Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis. Smith SW; Croft AP; Morris HL; Naylor AJ; Huso DL; Isacke CM; Savage CO; Buckley CD Nephron; 2015; 131(4):265-77. PubMed ID: 26633297 [TBL] [Abstract][Full Text] [Related]
32. The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring. Tang PM; Zhou S; Li CJ; Liao J; Xiao J; Wang QM; Lian GY; Li J; Huang XR; To KF; Ng CF; Chong CC; Ma RC; Lee TL; Lan HY Kidney Int; 2018 Jan; 93(1):173-187. PubMed ID: 29042082 [TBL] [Abstract][Full Text] [Related]
33. Janus-Faced: Molecular Mechanisms and Versatile Nature of Renal Fibrosis. Arai H; Yanagita M Kidney360; 2020 Jul; 1(7):697-704. PubMed ID: 35372942 [TBL] [Abstract][Full Text] [Related]
34. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation. Kida Y; Zullo JA; Goligorsky MS Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235 [TBL] [Abstract][Full Text] [Related]
35. Host responses in tissue repair and fibrosis. Duffield JS; Lupher M; Thannickal VJ; Wynn TA Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186 [TBL] [Abstract][Full Text] [Related]
36. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy. Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568 [TBL] [Abstract][Full Text] [Related]
37. TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Wang S; Meng XM; Ng YY; Ma FY; Zhou S; Zhang Y; Yang C; Huang XR; Xiao J; Wang YY; Ka SM; Tang YJ; Chung AC; To KF; Nikolic-Paterson DJ; Lan HY Oncotarget; 2016 Feb; 7(8):8809-22. PubMed ID: 26684242 [TBL] [Abstract][Full Text] [Related]
38. [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine]. Liu YL; Shi G; Cao DW; Wan YG; Wu W; Tu Y; Liu BH; Han WB; Yao J Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4192-4197. PubMed ID: 30583616 [TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice. Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126 [TBL] [Abstract][Full Text] [Related]
40. Huoxue Jiedu Huayu recipe alleviates contralateral renal fibrosis in unilateral ureteral obstruction rats by inhibiting the transformation of macrophages to myofibroblast. Yunzhao X; Lingjin L; Ziqian L; Gege C; Juan H; Xiaomeng G; Panpan Q; Zheng W; Qingyou XU J Tradit Chin Med; 2023 Feb; 43(1):105-112. PubMed ID: 36640001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]